Skip to main content
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: Hepatology. 2011 Jan;53(1):10.1002/hep.24074. doi: 10.1002/hep.24074

Table 2.

IL28B genotype frequency

(A) Overall IL28B genotype frequency
IL28B genotype frequency Overall Treated Not treated

Recipient* (n=171) (n=67) (n=104)
CC 56 (33%) 22 (33%) 34 (33%)
CT 87 (51%) 33 (49%) 54 (52%)
TT 28 (16%) 12 (18%) 16 (15%)
Undetermined 18 10 8
HWE**, Ψ2 P-value 0.55
Donor* (n=172) (n=74) (n=98)
CC 80 (47%) 33 (45%) 47 (48%)
CT 72 (42%) 36 (49%) 36 (37%)
TT 20 (12%) 5 (7%) 15 (15%)
Undetermined 17 3 14
HWE**, Ψ2 P-value 0.54
Donor vs recipient, Ψ2 P-value 0.0305
(B), Paired recipient:donor IL28B genotype frequency
IL28B genotype frequency Overall Treated Not treated

(n=155) (n=65) (n=90)
Donor non-CC : Recipient non-CC 52 (34%) 19 (29%) 33 (37%)
Donor CC : Recipient non-CC 50 (32%) 24 (37%) 26 (29%)
Donor non-CC : Recipient CC 29 (19%) 15 (23%) 14 (16%)
Donor CC : Recipient CC 24 (15%) 7 (11%) 17 (19%)
*

IL28B genotype was not determined from 18 recipients and 17 donor livers

**

HWE = Hardy-Weinberg equilibrium